Hadassah

Drug Company Collaborates with Hadassah Liver Specialist in Fighting Liver Disease

Wednesday, Jan 10 2018

Illustration of the positive impact of Namodenoson, as compared to treatment of animals with a placebo (“vehicle”)

Dr. Rifaat Safadi, head of the Hadassah Medical Organization’s Liver Unit, in its Institute of Gastroenterology and Liver Diseases, is collaborating with Can-Fite BioPharma Ltd. to explore further the healing effects of a new drug that has proven in preclinical studies to mitigate inflammatory diseases of the liver, such as NASH (non-alcoholic steatohepatitis).

The new drug called Namodenoson, Dr. Safadi says, “is unique among today’s NASH drugs under development due to its excellent safety profile and the positive effect on steatosis (accumulation of fat in the liver), inflammation, and fibrosis (liver scarring, which results from dying of liver cells, also referred to as ballooning).”  Improvement in these parameters translates into a significant anti-NASH effect.

Namodenoson has been granted Orphan Drug Designation in the United States and Europe and Fast Track Designation as a second-line treatment for hepatocellular cancer by the United States Food and Drug Administration. It has the potential to be effective in treating other cancers, including colon and prostate cancer, as well as melanoma.

Can-Fite has initiated enrollment for a Phase II study with Namodenoson in NASH and NAFLD (non-alcoholic fatty liver disease) patients who show evidence of active inflammation. The focus will be on measuring the drug’s anti-inflammatory effect and its success in reducing fat in the liver.

A prolific researcher, renowned for his work with NASH, Dr. Safadi is also a member of Can-Fite’s Clinical Advisory Board. “We are privileged to work with Dr. Safadi to further study and advance the drug’s mechanism of action,” notes Pnina Fishman, PhD, Founder and Chief Executive Officer of Can-Fite.

Learn more about the Hadassah Medical Organization.

Related Stories

alt_text

Wednesday, Feb 19 2020

Meet Dr. Ibrahim Abu Zahira, Hadassah Pediatric Cardiologist

The young doctor rings the doorbell on Star Street in Bethlehem, hoping the parents will still go along with...

READ MORE ›
alt_text

Wednesday, Feb 19 2020

A Hadassah Cardiologist, a New Baby, and a Parking Lot

It was dark and raining hard when cardiologist Prof. Ronen Beeri parked his car and hurried toward Hadassah Hospital Ein Kerem...

READ MORE ›
alt_text

Tuesday, Feb 18 2020

Hadassah Doctor Flies to Japan to Look After Israelis with Coronavirus

At the request of the Israel Health Ministry, Hadassah Medical Organization microbiology and infectious disease specialist...

READ MORE ›
alt_text

Tuesday, Feb 18 2020

Hadassah’s Holistic Hospice: A Small Haven with a Big Heart

Guided by a holistic approach, the hospice at Hadassah Hospital Mount Scopus helps patients and their loved ones...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More